標(biāo)題: Titlebook: Gene Therapy for Acute and Acquired Diseases; Phillip Factor Book 2001 Kluwer Academic Publishers 2001 HIV.Trauma.gene therapy.gene transf [打印本頁] 作者: corrode 時間: 2025-3-21 19:35
書目名稱Gene Therapy for Acute and Acquired Diseases影響因子(影響力)
書目名稱Gene Therapy for Acute and Acquired Diseases影響因子(影響力)學(xué)科排名
書目名稱Gene Therapy for Acute and Acquired Diseases網(wǎng)絡(luò)公開度
書目名稱Gene Therapy for Acute and Acquired Diseases網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Gene Therapy for Acute and Acquired Diseases被引頻次
書目名稱Gene Therapy for Acute and Acquired Diseases被引頻次學(xué)科排名
書目名稱Gene Therapy for Acute and Acquired Diseases年度引用
書目名稱Gene Therapy for Acute and Acquired Diseases年度引用學(xué)科排名
書目名稱Gene Therapy for Acute and Acquired Diseases讀者反饋
書目名稱Gene Therapy for Acute and Acquired Diseases讀者反饋學(xué)科排名
作者: 小蟲 時間: 2025-3-21 21:49
Gene Delivery in the ICU,h inflammatory mechanisms may modulate the acute inflammation accompanying many critical illnesses. Similarly, transgene expression that restores production of crucial biological mediators affected by the acute illness may be beneficial. Transgene expression need also not be limited to naturally occ作者: Restenosis 時間: 2025-3-22 01:15
Non-Viral Gene Therapy for Pulmonary Disease, administration of formulations comprising DNA and lipid, proteins, peptides or polymers. While the main limitation of non-viral gene transfer methods is their relatively low efficiency ., both preclinical and clinical studies indicate that these methods exhibit safety profiles similar to convention作者: GLARE 時間: 2025-3-22 07:07
Gene Therapy for Acute Lung Injury, Injury to the alveolar-capillary barrier and lung inflammation lead to intrapulmonary shunting of blood, surfactant depletion, and pulmonary vascular obstruction. Although the exact incidence of ARDS is unknown, there is little doubt that tens of thousands of patients develop this syndrome annually作者: 抵押貸款 時間: 2025-3-22 12:33
Gene Therapy for Preservation of Alveolar Endothelial and Epithelial Function,racellular adhesion molecules. More recently, it has been recognized that other alveolar proteins (e.g. antioxidants, solute transport or surfactant proteins) may also be compromised in ALI. Up to now, no avenues existed to restore the function of these proteins. Gene therapy and its potential to in作者: 濃縮 時間: 2025-3-22 13:00 作者: 濃縮 時間: 2025-3-22 18:19 作者: 折磨 時間: 2025-3-22 22:30 作者: Indecisive 時間: 2025-3-23 02:41
Gene Therapy for HIV and AIDS-Related Opportunistic Infections, recessive fashion and carry a significant morbidity, such as Cystic Fibrosis. However, as the field has expanded, it has taken advantage of the increasing knowledge base that there are genetic components to acquired disorders such as cancer, HIV infection and other infectious diseases. For example,作者: 完成 時間: 2025-3-23 06:14
Gene Therapy for Acute Kidney Diseases,onary hemorrhage. The incidence of acute renal failure is 5% of hospital admissions and 30% of intensive care unit patients (.). The incidence of ARF has not decreased over the past two decades despite improvement of diagnostic methods and advances in supportive care. While the survival from isolate作者: Affirm 時間: 2025-3-23 13:23
Gene Therapy Strategies to Augment Contractile Function in Heart Failure,nts in the management of coronary artery disease over the past decades, an effective treatment of CHF remains elusive. Heart failure itself represents a final common endpoint for several disease entities, including hypertension, coronary artery disease, and cardiomyopathy. Several biochemical featur作者: Abominate 時間: 2025-3-23 15:08 作者: manifestation 時間: 2025-3-23 18:19 作者: 掃興 時間: 2025-3-23 22:44 作者: 性滿足 時間: 2025-3-24 03:18 作者: Indicative 時間: 2025-3-24 10:21 作者: 單挑 時間: 2025-3-24 12:04
https://doi.org/10.1057/9781137290144h inflammatory mechanisms may modulate the acute inflammation accompanying many critical illnesses. Similarly, transgene expression that restores production of crucial biological mediators affected by the acute illness may be beneficial. Transgene expression need also not be limited to naturally occ作者: rheumatology 時間: 2025-3-24 16:07
Class, Culture and Social Change administration of formulations comprising DNA and lipid, proteins, peptides or polymers. While the main limitation of non-viral gene transfer methods is their relatively low efficiency ., both preclinical and clinical studies indicate that these methods exhibit safety profiles similar to convention作者: Solace 時間: 2025-3-24 20:23
Time, Myth and Power: , (2012), Injury to the alveolar-capillary barrier and lung inflammation lead to intrapulmonary shunting of blood, surfactant depletion, and pulmonary vascular obstruction. Although the exact incidence of ARDS is unknown, there is little doubt that tens of thousands of patients develop this syndrome annually作者: Judicious 時間: 2025-3-25 01:31 作者: 一大群 時間: 2025-3-25 06:24
https://doi.org/10.1007/978-3-030-16222-1yriad of endovascular or inhaled toxins, a series of temporally and spatially overlapping injury and repair events all too often result in a dysfunctional fibrotic lung. The fibroproliferative phase of acute lung injury is characterized by progressive accumulation of interstitial and alveolar myofib作者: FACET 時間: 2025-3-25 10:01
Class, Gender and the Family Businessraises the hope for treatment of otherwise incurable illnesses, such as asthma. Especially in need of new therapies are patients who require continuous oral glucocorticoids (GC), the so called GC-dependent patients. These patients are those who require particular medical attention, they are frequent作者: 金桌活畫面 時間: 2025-3-25 13:09
Paul Wetherly,Clyde W. Barrow,Peter Burnhambout cytokines has led to new studies of gene therapy for acquired diseases, including infectious diseases. In this chapter we focus on the potential applications of gene therapy to infectious diseases (Figure 1). We also briefly review recent advances in gene therapy for two inherited immunodeficie作者: 使聲音降低 時間: 2025-3-25 18:38
Class, Surplus, and the Division of Labour recessive fashion and carry a significant morbidity, such as Cystic Fibrosis. However, as the field has expanded, it has taken advantage of the increasing knowledge base that there are genetic components to acquired disorders such as cancer, HIV infection and other infectious diseases. For example,作者: Arctic 時間: 2025-3-25 20:36 作者: 非實體 時間: 2025-3-26 00:53 作者: 終端 時間: 2025-3-26 06:07
Classi caratteristiche e questioni connesses have demonstrated that various types of vectors (e.g. herpes simpex virus, adenovirus) can be used to transfect neurons, astrocytes, smooth muscle and endothelial cells in cell culture (., .). Selected . studies are reviewed.作者: 預(yù)測 時間: 2025-3-26 09:02 作者: 你正派 時間: 2025-3-26 13:47 作者: Adherent 時間: 2025-3-26 19:05
Classic Papers in Coronary Angioplastyture) is used to augment the native angiogenic process and enhance reperfusion of ischemic tissues (., .). Gene transfer is a means of achieving therapeutic angiogenesis, whereby the cDNA coding for specific angiogens, rather than the protein itself, is administered to tissues in which angiogenesis 作者: Tartar 時間: 2025-3-26 22:35 作者: Corroborate 時間: 2025-3-27 01:57
978-1-4613-5668-4Kluwer Academic Publishers 2001作者: 屈尊 時間: 2025-3-27 09:00 作者: 可用 時間: 2025-3-27 12:17 作者: 知識 時間: 2025-3-27 14:04 作者: 沙發(fā) 時間: 2025-3-27 19:47
ired disorders. It is expected that human gene therapytrials for these conditions will be forthcoming in the near future,leading to previously unimaginable therapies. Thus, this first-everbook about gene therapy for acute and acquired diseases is intended toserve as a glimpse into the future.978-1-4613-5668-4978-1-4615-1667-5作者: Nomogram 時間: 2025-3-27 23:10
Class, Capital and Social Policyite the institution of standard therapy aimed at the underlying process, many patients die secondary to the deleterious effects of the exaggerated systemic inflammatory response and end-organ damage seen in these disease states.作者: infinite 時間: 2025-3-28 05:36
Time, Myth and Power: , (2012),l advantages of giving therapeutic genes rather than giving proteins: 1) transfer of genes encoding intracellular proteins produces higher levels of therapeutic proteins within the cell, 2) gene transfer could be cell specific with modified vectors, 3) gene transfer may have less risk of antigenicit作者: Narcissist 時間: 2025-3-28 07:31
https://doi.org/10.1007/978-3-030-16222-1 of alveolar proteolysis, cell proliferation, apoptosis, angiogenesis, matrix synthesis and epithelial cell re-population provide ample and complementary biological pathways for targeting gene therapy (.–.). This chapter will review the alveolar architectural and biochemical abnormalities that occur作者: 失望未來 時間: 2025-3-28 10:52
Matthias Bernhard,Christian Wesselskynimal and azotemia is rapidly reversible by restoration of renal blood flow and glomerular filtration rate. Therefore, correction of renal perfusion is generally decisive in resolving pre-renal azotemia. Post-renal ARF occurs as a result of urinary tract obstruction, removal or bypass the obstructio作者: CRANK 時間: 2025-3-28 17:04 作者: 玩忽職守 時間: 2025-3-28 21:46 作者: 鞭子 時間: 2025-3-29 02:10 作者: 拋媚眼 時間: 2025-3-29 07:03 作者: 集合 時間: 2025-3-29 09:29
Book 2001cers. However, current gene transfertechnology is limited in its transduction efficiency and ability topermanently and safely correct genomic defects. Thus the promise ofgene therapy for these conditions is as yet unrealized. Theprogression of gene transfer technology will eventually surmount thesel作者: 可轉(zhuǎn)變 時間: 2025-3-29 12:14 作者: Negotiate 時間: 2025-3-29 16:35
Normalisers and prefrattini subgroups,ges in adrenergic signaling and calcium handling that occur in CHF. We will then examine the specific approaches to augment biochemical and physiologic function that address these alterations. Finally, we will review cardiac gene transfer vectors as well as technical approaches to myocardial gene delivery.作者: chronicle 時間: 2025-3-29 22:55
An Experimental Time-Sharing Systemal for intervention at early stages of organ procurement to prevent oxidative damage and cell death, during preservation to maintain viability, peri-transplant to promote acceptance by suppressing unwanted immune responses and post-transplant to promote long-term survival.作者: 不斷的變動 時間: 2025-3-30 02:11
Non-Viral Gene Therapy for Pulmonary Disease,tment for the acute lung injury and pulmonary oedema associated with the adult respiratory distress syndrome (ARDS). In this chapter, following a brief overview of non-viral gene transfer, the progress of both clinical studies for CF gene therapy and preclinical studies for pulmonary oedema are described.作者: 娘娘腔 時間: 2025-3-30 06:46 作者: assent 時間: 2025-3-30 08:31
Facilitation of Organ Transplantation with Gene Therapy,al for intervention at early stages of organ procurement to prevent oxidative damage and cell death, during preservation to maintain viability, peri-transplant to promote acceptance by suppressing unwanted immune responses and post-transplant to promote long-term survival.作者: 擁護者 時間: 2025-3-30 12:24
https://doi.org/10.1057/9781137290144urring biological products. For example, cDNA can be constructed that will encode for novel synthetic anti-microbial peptides with potential for use in sepsis or other infections. However, despite these possibilities, gene therapy for critical illnesses remains an underexplored area.作者: opprobrious 時間: 2025-3-30 17:33
Gene Delivery in the ICU,urring biological products. For example, cDNA can be constructed that will encode for novel synthetic anti-microbial peptides with potential for use in sepsis or other infections. However, despite these possibilities, gene therapy for critical illnesses remains an underexplored area.作者: caldron 時間: 2025-3-30 22:11
Gene Therapy for Preservation of Alveolar Endothelial and Epithelial Function,roteins) may also be compromised in ALI. Up to now, no avenues existed to restore the function of these proteins. Gene therapy and its potential to increase protein function has created the possibility of restoring or even augmenting alveolar function in the setting of ALI and as such offers tremendous promise for new treatments of ALI.作者: DIS 時間: 2025-3-31 03:42
Gene Therapy for Infectious Diseases,applications of gene therapy to infectious diseases (Figure 1). We also briefly review recent advances in gene therapy for two inherited immunodeficiency diseases that are associated with recurrent infections, chronic granulomatous disease and severe combined immunodeficiency. The topic of gene therapy for HIV disease is reviewed in chapter 12.作者: Tractable 時間: 2025-3-31 05:03 作者: 戰(zhàn)役 時間: 2025-3-31 11:37
Cardiac Angiogenesis and Gene Therapy: A Strategy for Myocardial Revascularization,peutic angiogenesis, whereby the cDNA coding for specific angiogens, rather than the protein itself, is administered to tissues in which angiogenesis is desired (., .). This review will focus on therapeutic angiogenesis based on gene transfer strategies for provision of myocardial revascularization.作者: Feckless 時間: 2025-3-31 15:17
ns and cancers. However, current gene transfertechnology is limited in its transduction efficiency and ability topermanently and safely correct genomic defects. Thus the promise ofgene therapy for these conditions is as yet unrealized. Theprogression of gene transfer technology will eventually surmo作者: COM 時間: 2025-3-31 19:23
Class, Ethnicity and Democracy in Nigeriaroteins) may also be compromised in ALI. Up to now, no avenues existed to restore the function of these proteins. Gene therapy and its potential to increase protein function has created the possibility of restoring or even augmenting alveolar function in the setting of ALI and as such offers tremendous promise for new treatments of ALI.作者: Physiatrist 時間: 2025-4-1 01:20
